West Pharmaceutical Services, Inc. (WST)
USD 211.29
(0.49%)
USD 211.29
(0.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 948.5 Million USD | 1.78% |
| 2022 | 931.9 Million USD | -4.75% |
| 2021 | 978.4 Million USD | 4.16% |
| 2020 | 939.3 Million USD | 22.27% |
| 2019 | 768.2 Million USD | 291.74% |
| 2018 | 196.1 Million USD | -0.46% |
| 2017 | 197 Million USD | -13.82% |
| 2016 | 228.6 Million USD | -23.34% |
| 2015 | 298.2 Million USD | -11.43% |
| 2014 | 336.7 Million USD | -56.0% |
| 2013 | 765.2 Million USD | -8.37% |
| 2012 | 835.1 Million USD | 12.21% |
| 2011 | 744.2 Million USD | 11.31% |
| 2010 | 668.6 Million USD | -3.37% |
| 2009 | 691.9 Million USD | 1.51% |
| 2008 | 681.6 Million USD | -1.89% |
| 2007 | 694.7 Million USD | 39.25% |
| 2006 | 498.9 Million USD | 2.65% |
| 2005 | 486 Million USD | 35.91% |
| 2004 | 357.6 Million USD | -2.3% |
| 2003 | 366 Million USD | 9.16% |
| 2002 | 335.3 Million USD | 0.24% |
| 2001 | 334.5 Million USD | -4.86% |
| 2000 | 351.6 Million USD | 9.94% |
| 1999 | 319.8 Million USD | 16.33% |
| 1998 | 274.9 Million USD | 37.59% |
| 1997 | 199.8 Million USD | -11.24% |
| 1996 | 225.1 Million USD | -0.31% |
| 1995 | 225.8 Million USD | 34.24% |
| 1994 | 168.2 Million USD | 55.17% |
| 1993 | 108.4 Million USD | -13.76% |
| 1992 | 125.7 Million USD | -17.36% |
| 1991 | 152.1 Million USD | -2.31% |
| 1990 | 155.7 Million USD | 25.36% |
| 1989 | 124.2 Million USD | -2.59% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 923 Million USD | 1.14% |
| 2024 Q1 | 921.7 Million USD | -2.83% |
| 2024 Q2 | 912.6 Million USD | -0.99% |
| 2023 Q2 | 922.9 Million USD | -2.59% |
| 2023 FY | 948.5 Million USD | 1.78% |
| 2023 Q1 | 947.4 Million USD | 1.66% |
| 2023 Q3 | 886.5 Million USD | -3.94% |
| 2023 Q4 | 948.5 Million USD | 6.99% |
| 2022 Q1 | 968.5 Million USD | -1.01% |
| 2022 FY | 931.9 Million USD | -4.75% |
| 2022 Q4 | 931.9 Million USD | 10.15% |
| 2022 Q3 | 846 Million USD | -9.74% |
| 2022 Q2 | 937.3 Million USD | -3.22% |
| 2021 FY | 978.4 Million USD | 4.16% |
| 2021 Q4 | 978.4 Million USD | 4.05% |
| 2021 Q3 | 940.3 Million USD | 4.37% |
| 2021 Q2 | 900.9 Million USD | -1.08% |
| 2021 Q1 | 910.7 Million USD | -3.04% |
| 2020 Q4 | 939.3 Million USD | 8.73% |
| 2020 Q1 | 256.7 Million USD | -66.58% |
| 2020 Q3 | 863.9 Million USD | 9.91% |
| 2020 Q2 | 786 Million USD | 206.19% |
| 2020 FY | 939.3 Million USD | 22.27% |
| 2019 Q4 | 768.2 Million USD | 293.75% |
| 2019 FY | 768.2 Million USD | 291.74% |
| 2019 Q1 | 195.5 Million USD | -0.31% |
| 2019 Q2 | 196 Million USD | 0.26% |
| 2019 Q3 | 195.1 Million USD | -0.46% |
| 2018 Q4 | 196.1 Million USD | -0.05% |
| 2018 Q2 | 196.4 Million USD | -0.81% |
| 2018 Q3 | 196.2 Million USD | -0.1% |
| 2018 Q1 | 198 Million USD | 0.51% |
| 2018 FY | 196.1 Million USD | -0.46% |
| 2017 Q2 | 229.5 Million USD | 0.39% |
| 2017 FY | 197 Million USD | -13.82% |
| 2017 Q4 | 197 Million USD | -14.27% |
| 2017 Q3 | 229.8 Million USD | 0.13% |
| 2017 Q1 | 228.6 Million USD | 0.0% |
| 2016 Q2 | 231.4 Million USD | -0.26% |
| 2016 FY | 228.6 Million USD | -23.34% |
| 2016 Q4 | 228.6 Million USD | -1.12% |
| 2016 Q3 | 231.2 Million USD | -0.09% |
| 2016 Q1 | 232 Million USD | -22.2% |
| 2015 FY | 298.2 Million USD | -11.43% |
| 2015 Q2 | 326.7 Million USD | -1.21% |
| 2015 Q1 | 330.7 Million USD | -1.78% |
| 2015 Q4 | 298.2 Million USD | -1.42% |
| 2015 Q3 | 302.5 Million USD | -7.41% |
| 2014 Q2 | 361.5 Million USD | -10.72% |
| 2014 FY | 336.7 Million USD | -56.0% |
| 2014 Q4 | 336.7 Million USD | -1.75% |
| 2014 Q1 | 404.9 Million USD | -47.09% |
| 2014 Q3 | 342.7 Million USD | -5.2% |
| 2013 FY | 765.2 Million USD | -8.37% |
| 2013 Q3 | 827.8 Million USD | -0.08% |
| 2013 Q2 | 828.5 Million USD | -0.32% |
| 2013 Q1 | 831.2 Million USD | -0.47% |
| 2013 Q4 | 765.2 Million USD | -7.56% |
| 2012 FY | 835.1 Million USD | 12.21% |
| 2012 Q4 | 835.1 Million USD | 3.06% |
| 2012 Q3 | 810.3 Million USD | 3.45% |
| 2012 Q2 | 783.3 Million USD | 2.71% |
| 2012 Q1 | 762.6 Million USD | 2.47% |
| 2011 Q3 | 707 Million USD | -1.71% |
| 2011 Q1 | 703 Million USD | 5.15% |
| 2011 Q4 | 744.2 Million USD | 5.26% |
| 2011 FY | 744.2 Million USD | 11.31% |
| 2011 Q2 | 719.3 Million USD | 2.32% |
| 2010 FY | 668.6 Million USD | -3.37% |
| 2010 Q1 | 673.9 Million USD | -2.6% |
| 2010 Q2 | 651.1 Million USD | -3.38% |
| 2010 Q3 | 667.5 Million USD | 2.52% |
| 2010 Q4 | 668.6 Million USD | 0.16% |
| 2009 Q2 | 684.5 Million USD | 4.84% |
| 2009 Q3 | 698.2 Million USD | 2.0% |
| 2009 Q4 | 691.9 Million USD | -0.9% |
| 2009 Q1 | 652.9 Million USD | -4.21% |
| 2009 FY | 691.9 Million USD | 1.51% |
| 2008 FY | 681.6 Million USD | -1.89% |
| 2008 Q1 | 695.8 Million USD | 0.16% |
| 2008 Q3 | 672 Million USD | -4.22% |
| 2008 Q4 | 681.6 Million USD | 1.43% |
| 2008 Q2 | 701.6 Million USD | 0.83% |
| 2007 Q3 | 668.4 Million USD | 3.85% |
| 2007 Q4 | 694.7 Million USD | 3.93% |
| 2007 Q2 | 643.6 Million USD | 0.28% |
| 2007 Q1 | 641.8 Million USD | 28.64% |
| 2007 FY | 694.7 Million USD | 39.25% |
| 2006 Q1 | 485.6 Million USD | -0.08% |
| 2006 Q3 | 486.9 Million USD | -0.79% |
| 2006 Q4 | 498.9 Million USD | 2.46% |
| 2006 FY | 498.9 Million USD | 2.65% |
| 2006 Q2 | 490.8 Million USD | 1.07% |
| 2005 Q1 | 342.3 Million USD | -4.28% |
| 2005 FY | 486 Million USD | 35.91% |
| 2005 Q2 | 482.4 Million USD | 40.93% |
| 2005 Q3 | 469.6 Million USD | -2.65% |
| 2005 Q4 | 486 Million USD | 3.49% |
| 2004 Q3 | 355.3 Million USD | 2.69% |
| 2004 FY | 357.6 Million USD | -2.3% |
| 2004 Q1 | 341.7 Million USD | -6.64% |
| 2004 Q2 | 346 Million USD | 1.26% |
| 2004 Q4 | 357.6 Million USD | 0.65% |
| 2003 Q4 | 366 Million USD | 4.57% |
| 2003 Q2 | 345.7 Million USD | 3.22% |
| 2003 Q3 | 350 Million USD | 1.24% |
| 2003 Q1 | 334.9 Million USD | -0.12% |
| 2003 FY | 366 Million USD | 9.16% |
| 2002 Q3 | 322.7 Million USD | -2.6% |
| 2002 Q2 | 331.3 Million USD | 0.36% |
| 2002 FY | 335.3 Million USD | 0.24% |
| 2002 Q4 | 335.3 Million USD | 3.9% |
| 2002 Q1 | 330.1 Million USD | -1.32% |
| 2001 Q1 | 357.7 Million USD | 1.73% |
| 2001 Q4 | 334.5 Million USD | -9.94% |
| 2001 FY | 334.5 Million USD | -4.86% |
| 2001 Q3 | 371.4 Million USD | 3.0% |
| 2001 Q2 | 360.6 Million USD | 0.81% |
| 2000 FY | 351.6 Million USD | 9.94% |
| 2000 Q4 | 351.6 Million USD | 2.9% |
| 2000 Q3 | 341.7 Million USD | 3.08% |
| 2000 Q1 | 337.3 Million USD | 5.47% |
| 2000 Q2 | 331.5 Million USD | -1.72% |
| 1999 FY | 319.8 Million USD | 16.33% |
| 1999 Q3 | 305.7 Million USD | 0.39% |
| 1999 Q4 | 319.8 Million USD | 4.61% |
| 1999 Q2 | 304.5 Million USD | 11.74% |
| 1999 Q1 | 272.5 Million USD | -0.87% |
| 1998 Q1 | 244.3 Million USD | 22.27% |
| 1998 Q2 | 225.3 Million USD | -7.78% |
| 1998 Q3 | 242.3 Million USD | 7.55% |
| 1998 Q4 | 274.9 Million USD | 13.45% |
| 1998 FY | 274.9 Million USD | 37.59% |
| 1997 Q3 | 210.6 Million USD | -2.41% |
| 1997 Q1 | 222.8 Million USD | -1.02% |
| 1997 Q2 | 215.8 Million USD | -3.14% |
| 1997 Q4 | 199.8 Million USD | -5.13% |
| 1997 FY | 199.8 Million USD | -11.24% |
| 1996 FY | 225.1 Million USD | -0.31% |
| 1996 Q4 | 225.1 Million USD | 0.54% |
| 1996 Q1 | 227.6 Million USD | 0.8% |
| 1996 Q3 | 223.9 Million USD | -2.44% |
| 1996 Q2 | 229.5 Million USD | 0.83% |
| 1995 Q2 | 233.3 Million USD | 29.76% |
| 1995 Q1 | 179.8 Million USD | 6.9% |
| 1995 Q4 | 225.8 Million USD | 0.4% |
| 1995 FY | 225.8 Million USD | 34.24% |
| 1995 Q3 | 224.9 Million USD | -3.6% |
| 1994 Q2 | 134.2 Million USD | 13.25% |
| 1994 Q3 | 138.3 Million USD | 3.06% |
| 1994 Q4 | 168.2 Million USD | 21.62% |
| 1994 FY | 168.2 Million USD | 55.17% |
| 1994 Q1 | 118.5 Million USD | 9.32% |
| 1993 Q2 | 126 Million USD | 1.78% |
| 1993 FY | 108.4 Million USD | -13.76% |
| 1993 Q4 | 108.4 Million USD | -8.83% |
| 1993 Q3 | 118.9 Million USD | -5.63% |
| 1993 Q1 | 123.8 Million USD | -1.51% |
| 1992 Q2 | 141.6 Million USD | -3.34% |
| 1992 Q4 | 125.7 Million USD | -14.14% |
| 1992 FY | 125.7 Million USD | -17.36% |
| 1992 Q3 | 146.4 Million USD | 3.39% |
| 1992 Q1 | 146.5 Million USD | -3.68% |
| 1991 Q3 | 134.9 Million USD | -3.16% |
| 1991 Q4 | 152.1 Million USD | 12.75% |
| 1991 Q1 | 156.8 Million USD | 0.71% |
| 1991 FY | 152.1 Million USD | -2.31% |
| 1991 Q2 | 139.3 Million USD | -11.16% |
| 1990 Q1 | 130.6 Million USD | 5.15% |
| 1990 Q2 | 143 Million USD | 9.49% |
| 1990 Q4 | 155.7 Million USD | 6.06% |
| 1990 Q3 | 146.8 Million USD | 2.66% |
| 1990 FY | 155.7 Million USD | 25.36% |
| 1989 FY | 124.2 Million USD | -2.59% |
| 1989 Q4 | 124.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alcon Inc. | 8.98 Billion USD | 89.446% |
| AptarGroup, Inc. | 2.13 Billion USD | 55.482% |
| Baxter International Inc. | 19.8 Billion USD | 95.212% |
| Becton, Dickinson and Company | 26.98 Billion USD | 96.485% |
| Bausch + Lomb Corporation | 6.52 Billion USD | 85.457% |
| Haemonetics Corporation | 1.23 Billion USD | 23.238% |
| Envista Holdings Corp | 2.43 Billion USD | 60.986% |
| ResMed Inc. | 2 Billion USD | 52.772% |
| Teleflex Incorporated | 3.09 Billion USD | 69.32% |
| Warby Parker Inc. | 278.52 Million USD | -240.544% |